VCIM
CRBU icon

Velan Capital Investment Management’s Caribou Biosciences CRBU Stock Holding History

Velan Capital Investment Management’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-210,695
Closed -$1.14M – 25
2022
Q2 		$1.14M Hold
210,695
– – 1.16% 16
2022
Q1 		$1.93M Hold
210,695
– – 1.79% 16
2021
Q4 		$3.18M Buy
+210,695
New +$4.1M 2.47% 12

Other funds holding CRBU

PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EWM
Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Velan Capital Investment Management's CRBU Position: Q3 2022 in Review

Velan Capital Investment Management sold out of Caribou Biosciences (CRBU) in Q3 2022, closing a stake of 210,695 shares — an estimated $1.14M sold.

Velan Capital Investment Management first reported a position in CRBU in Q4 2021 and held it in 3 quarters. The position peaked at $3.18M in Q4 2021. 113 funds tracked by Wall St. Rank hold CRBU as of Q3 2022.

  • Velan Capital Investment Management reported no remaining Caribou Biosciences position as of Q3 2022 after selling out during the quarter.
  • Velan Capital Investment Management sold 210,695 Caribou Biosciences shares in Q3 2022, an estimated $1.14M.
  • Velan Capital Investment Management first reported a position in Caribou Biosciences in Q4 2021 and held it in 3 quarters.
  • Velan Capital Investment Management's Caribou Biosciences position peaked at $3.18M in Q4 2021.
  • 113 funds tracked by Wall St. Rank held Caribou Biosciences as of Q3 2022.

Based on Velan Capital Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.